Wind and wave power may provide all the future energy needs of GlaxoSmithKline”s Montrose site.
GSK has commissioned two studies into alternative energy opportunities as part of a drive to reduce the factory’s carbon footprint.
The studies indicate that wind turbine and marine power generation technologies could offer potential solutions to help the site become carbon neutral and more cost-effective.
A GSK spokesman said, “Although it is too early to be specific about potential schemes or their costs, we have held preliminary discussions with officers of Angus Council to share initial thinking.
“We have identified some exciting opportunities, although they require further investigation to fully confirm their potential.”
The site is investing over £2m installing combined heat and power technology due to come on stream later this summer.
The gas engine unit, which generates electricity and provides ‘free’ heat as a by-product, will cut energy bills by an estimated £350,000 per year and reduce carbon dioxide emissions by 2700 tonnes annually.
A spokesman for Angus Council confirmed that officers of the council have had initial discussions with GSK on a range of sustainable energy issues.
It has been estimated that providing the necessary on-site turbines and wave power in Montrose Bay to meet the factory’s demand could cost GSK £15m.